Literature DB >> 18580307

Loss of heterozygosity in endometrial carcinoma.

Ana Velasco1, Judit Pallares, Maria Santacana, Andre Yeramian, Xavier Dolcet, Nuria Eritja, Soraya Puente, Anabel Sorolla, Nuria Llecha, Xavier Matias-Guiu.   

Abstract

Inactivation of a tumor suppressor gene typically occurs in two steps, thus fulfilling Knudson hypothesis. One "hit" is frequently a point mutation or a small deletion. The other alteration is usually a large genomic loss of part of a gene, or even part of a chromosome, or the whole chromosome. However, it is not clear which of these two events occurs first. Loss of heterozygosity (LOH) analysis allows the identification of one of the 2 hits. Although microsatellite polymerase chain reaction is the technique most frequently used to assess LOH, other different approaches can also be used. The LOH can also be assessed by restriction fragment length polymorphism analysis, single strand conformation polymorphism analysis, oligonucleotide microarrays capable to simultaneously determine the genotype of thousands of single-nucleotide polymorphism (single-nucleotide polymorphism arrays), comparative genomic hybridization, multiplex amplification and probe hybridization, and multiplex ligation-dependent probe amplification. In this article, the authors review the results obtained with molecular analysis of LOH in the understanding of development and progression of endometrial carcinoma. Particular attention is given to: (1) the presence of widespread LOH in nonendometrioid carcinoma, probably reflecting the existence of chromosomal instability; and (2) specific LOH patterns associated with some clinicopathologic features.

Entities:  

Mesh:

Year:  2008        PMID: 18580307     DOI: 10.1097/PGP.0b013e31815daf1a

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  3 in total

1.  Allelic loss at TP53 in metastatic human endometrial carcinomas.

Authors:  Wiktor Szewczuk; Danuta Skomra; Marek Cybulski; Dorota Przadka-Rabaniuk; Agata Filip; Maciej Jóźwik; Piotr Olcha; Albert Roessner; Andrzej Semczuk
Journal:  Clin Exp Metastasis       Date:  2009-06-30       Impact factor: 5.150

2.  Loss of Heterozygosity for KrasG12D Promotes Malignant Phenotype of Pancreatic Ductal Adenocarcinoma by Activating HIF-2α-c-Myc-Regulated Glutamine Metabolism.

Authors:  Yu Ma; Sunkai Ling; Yuan Li; Mingyue Hu; Bo Kong; Peilin Huang; Hui Liu
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

3.  Alpha internexin expression related with molecular characteristics in adult glioblastoma and oligodendroglioma.

Authors:  Ja Hee Suh; Chul-Kee Park; Sung-Hye Park
Journal:  J Korean Med Sci       Date:  2013-03-27       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.